Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors
Sign Up to like & getrecommendations! Published in 2024 at "Cancer Discovery"
DOI: 10.1158/2159-8290.cd-23-1060
Abstract: Change in cell-free DNA methylomes and fragmentomes after just two cycles of pembrolizumab were associated with progression-free and overall survival in patients with various metastatic cancers, without requiring matched tumor tissue. read more here.
Keywords: tumor naive; cell free; changes tumor; early changes ... See more keywords